Cubist Pharmaceuticals Inc. (CBST) Financials Nov

Cubist Pharmaceuticals Inc. (CBST) Financials Nov 18, 2014, 5:23 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Cubist Pharmaceuticals Inc.


Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 562.14M 636.46M 753.97M 926.36M 1.05B
Cost of Goods Sold (COGS) incl. D&A 116.89M 140.77M 172.86M 230.06M 260.31M
COGS excluding D&A 103.95M 128.8M 160.36M 196.78M 217.12M
Depreciation & Amortization Expense 12.94M 11.97M 12.51M 33.28M 43.19M
Depreciation 10M 9M 9M 12.38M 14.4M
Amortization of Intangibles 2.94M 2.97M 3.51M 20.9M 28.79M
Gross Income 445.26M 495.69M 581.11M 696.3M 794.13M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 300.7M 301.2M 339.66M 449.52M 688.08M
Research & Development 166.28M 157.85M 184.53M 277.73M 452.74M
Other SG&A 134.42M 143.34M 155.13M 171.79M 235.34M
Other Operating Expense 0 0 0 0 0
Unusual Expense 6.8M 4.9M 108.92M 9.68M 79.64M
EBIT after Unusual Expense (6.8M) (4.9M) (108.92M) (9.68M) (79.64M)
Non Operating Income/Expense (1.23M) (14.41M) 1M (7.6M) (34.89M)
Non-Operating Interest Income 4.26M 4.7M 2.67M 3.08M 2.44M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 20.89M 25.58M 31.42M 32.99M 37.6M
Gross Interest Expense 20.89M 25.58M 33.98M 32.99M 37.6M
Interest Capitalized 0 0 2.57M 0 0
Pretax Income 119.9M 154.31M 104.79M 199.6M (43.64M)
Income Tax 40.3M 59.98M 71.77M 45.52M (25.07M)
Income Tax - Current Domestic 6.18M 24.84M 63.05M 78.46M 13.91M
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 34.12M 35.15M 8.72M (32.94M) (38.98M)
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 79.6M 94.33M 33.02M 154.08M (18.57M)
Minority Interest Expense 0 0 0 0 0
Net Income 79.6M 94.33M 33.02M 154.08M (18.57M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 79.6M 94.33M 33.02M 154.08M (18.57M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 79.6M 94.33M 33.02M 154.08M (18.57M)
EPS (Basic) 1.38 1.60 0.54 2.42 (0.27)
Basic Shares Outstanding 57.75M 58.8M 60.84M 63.77M 68.16M
EPS (Diluted) 1.36 1.51 0.52 2.10 (0.27)
Diluted Shares Outstanding 68.38M 62.66M 62.94M 81.44M 68.16M
EBITDA 157.5M 206.47M 253.96M 280.06M 149.25M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.